Hematology. American Society of Hematology. Education ProgramHumansT-LymphocytesLymphomaNon-HodgkinAntibodies
Emerging immunotherapy advances for non-Hodgkin lymphomas: engaging T cells in the fight.
Alexandra E Rojek, Sonali M Smith
Published: 202510.1182/hematology.2025000722
Abstract
The treatment landscape of B-cell non-Hodgkin lymphoma (B-NHL) has been rapidly transformed by the emergence of T-cell engaging (TCE) therapies. Within the past decade, anti-CD19 chimeric antigen receptor (CAR) T-cell therapies have moved from relaps…
Preview only. Read the full abstract at the source